Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New prospectives on treatment opportunities in RASopathies
Bruce D. Gelb, Marielle E. Yohe, Cordula M. Wolf, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2022) Vol. 190, Iss. 4, pp. 541-560
Open Access | Times Cited: 23

Showing 23 citing articles:

Novel therapeutic perspectives in Noonan syndrome and RASopathies
Céline Saint-Laurent, Laurène Mazeyrie, Armelle Yart, et al.
European Journal of Pediatrics (2023) Vol. 183, Iss. 3, pp. 1011-1019
Open Access | Times Cited: 18
Exploring New Drug Repurposing Opportunities for MEK Inhibitors in RASopathies: A Comprehensive Review of Safety, Efficacy, and Future Perspectives of Trametinib and Selumetinib
Andrea Gazzin, Federico Fornari, Simona Cardaropoli, et al.
Life (2024) Vol. 14, Iss. 6, pp. 731-731
Open Access | Times Cited: 6
ADrosophilamodel for Costello Syndrome caused by Ras mutation K117R
Prashath Karunaraj, Elton Cao, Hina Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Trametinib as a targeted treatment in cardiac and lymphatic presentations of Noonan syndrome
Isabel De Brouchoven, Juan Lorand, Léon Bofferding, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Cardiovascular aspects of Noonan syndrome and related disorders
Martin Zenker, Cordula M. Wolf
Medizinische Genetik (2025) Vol. 37, Iss. 2, pp. 113-124
Closed Access
MEK Inhibition for RASopathy-Associated Hypertrophic Cardiomyopathy: Clinical Application of a Basic Concept
Dominic Chaput, Grégor Andelfinger
Canadian Journal of Cardiology (2024) Vol. 40, Iss. 5, pp. 789-799
Closed Access | Times Cited: 4
Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature
Christopher Iriarte, Jennifer Yeh, Allireza Alloo, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 9
Closed Access | Times Cited: 2
PRKAG2‐Related Lethal Congenital Glycogen Storage Disease of the Heart as Rare Cause of Fetal Hydrops With Bradycardia and Cardiomyopathy: Clinical Report and Literature Review
Alexandre White‐Brown, Marilyn Richard, Anne‐Maude Morency, et al.
American Journal of Medical Genetics Part A (2024)
Open Access | Times Cited: 2
ASXL1 truncating variants in BOS and myeloid leukemia drive shared disruption of Wnt-signaling pathways but have differential isoform usage of RUNX3
Isabella Lin, Zain Awamleh, Mili Sinvhal, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy
Gianluca D’Onofrio, Marie‐Ange Delrue, Anne Lortie, et al.
Pediatric Neurology (2023) Vol. 148, pp. 148-151
Closed Access | Times Cited: 6
The Surgical Management of Severe Scoliosis in Immature Patient with a Very Rare Disease Costello Syndrome—Clinical Example and Brief Literature Review
Paweł Grabala, P.M. Kowalski, Marek J. Rudziński, et al.
Life (2024) Vol. 14, Iss. 6, pp. 740-740
Open Access | Times Cited: 1
Refractory Chylothorax and Ventricular Hypertrophy Treated with Trametinib in a Patient with Noonan Syndrome: 18-Month Follow-Up
Antonia Pascarella, Giuseppe Limongelli, Alessandro De Falco, et al.
Children (2024) Vol. 11, Iss. 11, pp. 1342-1342
Open Access | Times Cited: 1
Co-Occurring Thrombotic Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia in a Child Carrying the Pathogenic SHOC2 c.4A>G (p.Ser2Gly) Variant
Lijun Liu, Chanchan Hu, Zhenjie Chen, et al.
American Journal of Case Reports (2023) Vol. 24
Open Access | Times Cited: 2
Assessment of the FRET-based Teen sensor to monitor ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Giulia Fasano, Stefania Petrini, Valeria Bonavolontà, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access
Cardiac Phenotype and Gene Mutations in RASopathies
Maria Felicia Faienza, Giovanni Meliota, Donatella Mentino, et al.
Genes (2024) Vol. 15, Iss. 8, pp. 1015-1015
Open Access
Peptide-based therapeutics targeting genetic disorders
Shweta Subramanian, Meenakshi Jain, Rajkumar Misra, et al.
Drug Discovery Today (2024), pp. 104209-104209
Closed Access
Human Developmental Genetics
Wen‐Hann Tan
Elsevier eBooks (2024), pp. 1-68
Closed Access
Designing therapies relevant in human genetic disorders
Moyra Smith
Elsevier eBooks (2024), pp. 355-406
Closed Access
Trametinib alters contractility of paediatric Noonan syndrome‐associated hypertrophic myocardial tissue slices
Jules Hamers, Payel Sen, Sarala Raj Murthi, et al.
ESC Heart Failure (2024)
Open Access
Costello Syndrome
Yoko Aoki, Tetsuya Niihori
(2024), pp. 133-151
Closed Access
Clinical Studies and Small Molecule Inhibitors for RASopathy Treatment
Andrea M. Gross, Marielle E. Yohe, Brigitte C. Widemann
(2024), pp. 895-908
Closed Access
Lessons From a Genotype-Phenotype Study About the Clinical Spectrum of Hypertrophic Cardiomyopathy Associated With Noonan Syndrome With Multiple Lentigines and PTPN11-Mutations
Ingegerd Östman‐Smith
Circulation Genomic and Precision Medicine (2023) Vol. 16, Iss. 4, pp. 359-362
Closed Access
FRET imaging of Teen sensor captures ERK activation changes preceding morphological defects in a RASopathy zebrafish model and phenotypic rescue by MEK inhibitor
Giulia Fasano, Stefania Petrini, Valeria Bonavolontà, et al.
Research Square (Research Square) (2023)
Open Access
Genotype-Phenotype Correlation in Noonan Syndrome – Focus on LZTR1 and its Substrates
Alexandra Viktoria Busley
(2023)
Open Access
Page 1

Scroll to top